Back
Terreno Realty 10K Form
Sell
40
TRNO
Terreno Realty
Last Price:
60.39
Seasonality Move:
4.8%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-08 | 10Q | TRNO/Terreno Realty Quarterly |
2023-11-01 | 10Q | TRNO/Terreno Realty Quarterly |
2023-08-02 | 10Q | TRNO/Terreno Realty Quarterly |
2023-05-03 | 10Q | TRNO/Terreno Realty Quarterly |
2022-11-02 | 10Q | TRNO/Terreno Realty Quarterly |
2022-08-03 | 10Q | TRNO/Terreno Realty Quarterly |
Receive TRNO News And Ratings
See the #1 stock for the next 7 days that we like better than TRNO
TRNO Financial Statistics
Sales & Book Value
Annual Sales: | $323.59M |
---|---|
Cash Flow: | $56.19M |
Price / Cash Flow: | 31.61 |
Annual Sales: | $36.60 |
Price / Book: | 1.65 |
Profitability
EPS (TTM): | 1.82000 |
---|---|
Net Income (TTM): | $165.95M |
Gross Margin: | $244.51M |
Return on Equity: | 5.13% |
Return on Assets: | 3.93% |
Terreno Realty Earnings Forecast
Key Terreno Realty Financial Ratios
- The Gross Profit Margin over the past 15 years for TRNO is 75.56%.
- The Selling, General & Administrative Expenses for TRNO have been equal to 11.72% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 16.37% of Operating Income.
- The Net Earning history of TRNO is 46.81% of Total Revenues.
- Per Share Earnings over the last 15 years have been positive in 9 years.
Terreno Realty Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYSE |
---|---|
Industry: | Industrial REITs |
Sector: | Real Estate |
Current Symbol: | TRNO |
CUSIP: | 88146M |
Website: | terreno.com |
Debt
Debt-to-Equity Ratio: | 0.19 |
---|---|
Current Ratio: | 1.84 |
Quick Ratio: | 1.76 |
Price-to-Earnings
Trailing P/E Ratio: | 33.28 |
---|---|
Forward P/E Ratio: | 30.37 |
TRNO Technical Analysis vs Fundamental Analysis
Sell
40
Terreno Realty (TRNO)
is a Sell
Is Terreno Realty a Buy or a Sell?
-
Terreno Realty stock is rated a Sell
The current Terreno Realty [TRNO] share price is $60.23. The Score for TRNO is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.